Filing Details
- Accession Number:
- 0001178913-21-001591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-04 13:00:00
- Reporting Period:
- 2021-05-04
- Accepted Time:
- 2021-05-04 13:21:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1785530 | Werewolf Therapeutics Inc. | HOWL | () | L3 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1496201 | Ltd. Management Funds Sphera | C/O Sphera Funds Management Ltd. 21 Ha'Arba'Ah Street Tel Aviv L3 64739 | No | No | Yes | No | |
| 1599854 | Sphera Global Healthcare Management Lp | C/O Sphera Funds Management Ltd. 21 Ha'Arba'Ah Street Tel Aviv L3 64739 | No | No | Yes | No | |
| 1599855 | Ltd. Gp Healthcare Global Sphera | C/O Sphera Funds Management Ltd. 21 Ha'Arba'Ah Street Tel Aviv L3 64739 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-04 | 312,997 | $0.00 | 312,997 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-05-04 | 475,000 | $16.00 | 787,997 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2021-05-04 | 2,713,410 | $0.00 | 312,997 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- Includes (a) 187,798 shares held by Sphera Global Healthcare Master Fund (the "Healthcare Fund") and (b) 125,199 shares held by SpheraBiotech Master Fund, LP (the "Biotech Fund" and, together with the Healthcare Fund, the "Funds").
- On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- Sphera Global Healthcare Management LP is the investment manager for the Funds (the "Management Company"). The Management Company is managed, controlled and operated by its general partner Sphera Global Healthcare GP Ltd. (the "General Partner"), of which Sphera Funds Management Ltd. ("SFML") is the controlling shareholder. Each of the Management Company, the General Partner and SFML may be deemed the indirect beneficial owner of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
- Includes (a) 300,000 shares held by the Healthcare Fund and (b) 175,000 shares held by the Biotech Fund.
- Includes (a) 487,798 shares held by the Healthcare Fund and (b) 300,199 shares held by Biotech Fund.
Billionaire Hedge Funds
